Instead, non-classical co-stimulatory receptors beyond CD80/86 can be expressed by some cancer cells and are sufficient to activate certain T cell subsets [71,107], for example CD70, OX40-ligand, as well as molecules from adjacent, juxtaposed immune cells in the tumor microenvironment [108,109,110]. The gene discussed is CD80; the disease is neoplasm.